Avenue Therapeutics, Inc. (ATXI)
ATXI Stock Price Chart
Explore Avenue Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ATXI price movements and trends.
ATXI Company Profile
Discover essential business fundamentals and corporate details for Avenue Therapeutics, Inc. (ATXI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Jun 2017
Employees
2.00
Website
https://www.avenuetx.comCEO
Alexandra MacLean
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
ATXI Financial Timeline
Browse a chronological timeline of Avenue Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at $0.11 , while revenue for the quarter reached $1.40M .
Earnings released on 15 May 2025
EPS came in at -$0.62 .
Earnings released on 31 Mar 2025
EPS came in at $1.48 .
Earnings released on 14 Nov 2024
EPS came in at -$1.92 falling short of the estimated -$0.94 by -104.26%.
Earnings released on 9 Aug 2024
EPS came in at -$6.43 falling short of the estimated -$1.05 by -512.38%.
Earnings released on 15 May 2024
EPS came in at -$15.40 falling short of the estimated -$9.00 by -71.11%.
Stock split effective on 26 Apr 2024
Shares were split 1 : 75 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 18 Mar 2024
EPS came in at $42.11 surpassing the estimated -$0.10 by +42.21K%.
Earnings released on 13 Nov 2023
EPS came in at $4.51 surpassing the estimated -$0.26 by +1.83K%.
Earnings released on 10 Aug 2023
EPS came in at -$39.10 falling short of the estimated -$0.29 by -13.38K%.
Earnings released on 12 May 2023
EPS came in at -$103.01 falling short of the estimated -$0.13 by -79.14K%.
Earnings released on 30 Mar 2023
EPS came in at $92.48 surpassing the estimated -$0.15 by +61.75K%.
Earnings released on 10 Nov 2022
EPS came in at -$33.83 surpassing the estimated -$45.00 by +24.82%.
Stock split effective on 23 Sept 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Aug 2022
EPS came in at -$33.82 surpassing the estimated -$45.00 by +24.84%.
Earnings released on 16 May 2022
EPS came in at -$2.05 surpassing the estimated -$45.00 by +95.45%.
Earnings released on 25 Mar 2022
EPS came in at -$0.75 falling short of the estimated -$0.60 by -25.04%.
Earnings released on 15 Nov 2021
EPS came in at -$56.36 .
Earnings released on 16 Aug 2021
EPS came in at -$67.64 .
Earnings released on 17 May 2021
EPS came in at -$67.64 falling short of the estimated -$0.90 by -7.42K%.
Earnings released on 31 Mar 2021
EPS came in at -$67.64 falling short of the estimated -$0.90 by -7.42K%.
Earnings released on 4 Nov 2020
EPS came in at -$67.64 surpassing the estimated -$112.73 by +40.00%.
ATXI Stock Performance
Access detailed ATXI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.